(Q90749035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

title

Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

M Schwermer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

M Hiber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

S Dreesmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

A Rieb

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

J Theißen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

T Herold

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

A Schramm

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

P Temming

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

L Steenpass

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

publication date

22 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

16 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

volume

375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

page(s)

92-99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides

16 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Neuroblastoma: biological insights into a clinical enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Re-characterization of established human retinoblastoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

p53 is a direct transcriptional target of MYCN in neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Genomic gains on chromosome 1q in retinoblastoma: consequences on gene expression and association with clinical manifestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Newly established human retinoblastoma cell lines exhibit an "immortalized" but not an invasive phenotype in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Gene expression profiling identifies different sub-types of retinoblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Topotecan combination chemotherapy in two new rodent models of retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Targeting MDM2 and MDMX in retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Molecular mechanism of retinoblastoma gene inactivation in retinoblastoma cell line Y79

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Globe conserving treatment of the only eye in bilateral retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Molecular genetics of RB1--the retinoblastoma gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Coexpression of normally incompatible developmental pathways in retinoblastoma genesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

RB1 gene inactivation by chromothripsis in human retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Mutant p53 in cancer: new functions and therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Animal models in retinoblastoma research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

"Retinoblastoma survival disparity": The expanding horizon in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Identification of genes that are regulated transcriptionally by Myc in childhood tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

A Study of Gene Expression of Survivin, its Antiapoptotic Variants, and Targeting Survivin In Vitro for Therapy in Retinoblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Analyzing real-time PCR data by the comparative C(T) method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

A Mouse Model for Imprinting of the Human Retinoblastoma Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

Rb suppresses human cone-precursor-derived retinoblastoma tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

A novel retinoblastoma therapy from genomic and epigenetic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.12.018

10.1016/J.YEXCR.2018.12.018

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30584916%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference